NCT06676527 2025-12-05
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
Recruiting
Jinling Hospital, China
Ludwig-Maximilians - University of Munich
Zhujiang Hospital
Medical University of Graz
IRCCS San Raffaele